Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 17, Number 1—January 2011

Research

Completeness of Communicable Disease Reporting, North Carolina, USA, 1995–1997 and 2000–2006

Emily E. Sickbert-BennettComments to Author , David J. Weber, Charles Poole, Pia D.M. MacDonald, and Jean-Marie Maillard
Author affiliations: Author affiliations: University of North Carolina Health Care System, Chapel Hill, North Carolina, USA (E.E. Sickbert-Bennett, D.J. Weber); University of North Carolina, Chapel Hill (E.E. Sickbert-Bennett, D.J. Weber, C. Poole, P.D.M. MacDonald); North Carolina Department of Health and Human Services, Raleigh, North Carolina, USA (J.-M. Maillard)

Main Article

Table

. Disease-specific reporting completeness proportions in North Carolina, USA, 2000–2006*

Communicable disease No. reported to NC DHHS No. identified by ICD-9-CM codes Unadjusted RCP, % (95% CI) Semi-Bayesian adjusted
RCP, % (95% UI)
Anthrax 0 14 0.01 (0.00–100.00) 0.00 (0.00–100.00)
Arboviral encephalitis 0 18 0.00 (0.00–100.00) 8.67 (0.80–52.77)
Botulism 0 4 0.02 (0.00–100.00) 0.08 (0.00–100.00)
Brucellosis 0 33 0.00 (0.00–100.00) 23.02 (1.36–86.62)
Campylobacteriosis 39 97 40.21 (30.94–50.22) 39.96 (30.82–49.85)
Cholera 0 6 0.01 (0.00–100.00) 18.58 (2.24–69.41)
CJD/vCJD 0 32 0.00 (0.00–100.00) 0.87 (0.03–22.97)
Cryptosporidiosis 10 84 11.90 (6.53–20.73) 12.59 (7.07–21.42)
Cyclosporiasis 0 3 0.03 (0.00–100.00) 18.59 (2.25–69.42)
Dengue 4 25 16.00 (6.14–35.69) 14.48 (5.92–31.31)
Diphtheria 0 5 0.02 (0.00–100.00) 8.28 (0.82–49.70)
Escherichia coli infection 1 3 33.33 (4.34–84.65) 24.67 (5.82–63.45)
Foodborne staphylococcal infection 0 14 0.01 (0.00–100.00) 74.74 (16.74–97.76)
Granulocytic ehrlichiosis 0 67 0.00 (0.00–100.00) 8.66 (0.80–52.74)
Hantavirus infection 0 3 0.03 (0.00–100.00) 10.10 (0.62–67.06)
Hemolytic uremic syndrome 5 429 1.17 (0.49–2.77) 2.20 (0.99–4.84)
Hemophilus Influenzae 14 1,086 1.29 (0.76–2.16) 1.45 (0.87–2.42)
Hepatitis A 27 866 3.12 (2.15–4.51) 3.34 (2.31–4.81)
Legionellosis 24 98 24.49 (16.99–33.95) 24.04 (16.72–33.27)
Leptospirosis 0 33 0.00 (0.00–100.00) 23.02 (1.36–86.62)
Listeriosis 10 64 15.63 (8.62–26.67) 16.14 (9.12–26.95)
Lyme disease 8 790 1.01 (0.51–2.01) 1.18 (0.60–2.30)
Malaria 17 155 10.97 (6.93–16.94) 10.71 (6.80–16.47)
Measles 0 14 0.01 (0.00–100.00) 15.98 (1.41–71.63)
Meningococcal disease 38 179 21.23 (15.85–27.83) 21.19 (15.85–27.73)
Monocytic ehrlichiosis 1 4 25.00 (3.35–76.22) 14.84 (3.12–48.52)
Mumps 1 96 1.04 (0.15–7.02) 1.07 (0.20–5.49)
Plague 0 28 0.00 (0.00–100.00) 0.00 (0.00–100.00)
Pneumococcal meningitis 20 191 10.47 (6.86–15.67) 10.61 (6.99–15.80)
Polio, paralytic 0 32 0.00 (0.00–100.00) 18.56 (2.24–69.38)
Psittacosis 0 21 0.00 (0.00–100.00) 17.45 (1.57–73.69)
Q fever 3 14 21.43 (7.07–49.43) 25.68 (9.14–54.28)
Rabies, human 0 12 0.01 (0.00–100.00) 59.69 (8.00–96.19)
Rocky Mountain spotted fever 40 986 4.06 (2.99–5.48) 4.19 (3.10–5.66)
Rubella 0 39 0.00 (0.00–100.00) 15.97 (1.41–71.61)
Rubella congenital syndrome 0 10 0.01 (0.00–100.00) 1.08 (0.07–15.32)
Salmonellosis 263 594 44.28 (40.33–48.30) 44.82 (40.87–48.83)
SARS (coronavirus infection) 0 1 0.08 (0.00–100.00) 5.71 (0.28–56.27)
Shigellosis 38 213 17.84 (13.26–23.57) 18.17 (13.56–23.93)
Smallpox 0 9 0.01 (0.00–100.00) 0.00 (0.00–100.00)
Streptococcal infection, group A 8 111 7.21 (3.65–13.75) 7.40 (3.80–13.92)
Tetanus 1 20 5.00 (0.70–28.22) 5.25 (1.09–21.78)
Toxic shock syndrome 4 142 2.82 (1.06–7.26) 3.22 (1.28–7.83)
Trichinosis 0 23 0.00 (0.00–100.00) 20.21 (1.82–77.58)
Tuberculosis 100 1,439 6.95 (5.74–8.38) 7.10 (5.87–8.55)
Tularemia 0 6 0.01 (0.00–100.00) 0.04 (0.00–100.00)
Typhoid, acute 3 12 25.00 (8.28–55.18) 21.57 (7.49–48.30)
Typhus, epidemic (louse-borne) 0 2 0.04 (0.00–100.00) 2.93 (0.12–42.63)
Vaccinia 0 13 0.01 (0.00–100.00) 8.27 (0.82–49.68)
Vibrio spp. infection, other 0 1 0.08 (0.00–100.00) 81.58 (20.46–98.71)
Vibrio vulnificus infection 0 2 0.04 (0.00–100.00) 81.57 (20.45–98.71)
Whooping cough (pertussis) 11 54 20.37 (11.65–33.16) 20.31 (11.78–32.72)
Yellow fever 0 3 0.03 (0.00–100.00) 8.69 (0.80–52.81)

*NC DHHS, North Carolina Department of Health and Human Services; ICD-9-CM, International Classification of Diseases, 9th Revision, Clinical Modification; RCP, reporting completeness proportions; CI, confidence interval; UI, uncertainty interval; CJD, Creutzfeldt-Jakob disease; vCJD, variant CJD; SARS, severe acute respiratory syndrome.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO